tiprankstipranks
Fennec Pharmaceuticals (FENC)
NASDAQ:FENC
US Market

Fennec Pharmaceuticals (FENC) Income Statement

Compare
225 Followers

Fennec Pharmaceuticals Income Statement

Last quarter (Q3 2024), Fennec Pharmaceuticals's total revenue was $6.97M, an increase of 7.05% from the same quarter last year. In Q3, Fennec Pharmaceuticals's net income was $-5.74M. See Fennec Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 21.25M$ 1.53M$ 0.00$ 170.00K$ 0.00
Gross Profit
$ 19.99M$ 1.45M$ 0.00$ 170.00K$ 0.00
Operating Expenses
$ 32.76M$ 24.04M$ 17.22M$ 18.05M$ 13.01M
Depreciation and Amortization
$ 287.00K$ 149.00K$ 17.22M$ 402.00K$ 13.01M
EBITDA
$ -12.36M$ -22.59M$ -17.18M$ -17.98M$ -13.01M
Operating Income
$ -12.77M$ -22.59M$ -17.22M$ -17.89M$ -13.01M
Other Income/Expenses
$ -3.27M$ -1.13M$ -123.00K$ -224.00K$ 234.00K
Pretax Income
$ -16.05M$ -23.71M$ -17.35M$ -18.11M$ -12.78M
Net Income
$ -16.05M$ -23.86M$ -17.46M$ -17.92M$ -12.46M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -0.60$ -0.91$ -0.67$ -0.76$ -0.63
Diluted EPS
$ -0.60$ -0.91$ -0.67$ -0.76$ -0.63
Weighted Average Shares Outstanding
26.57M 26.27M 25.89M 23.70M 19.90M
Weighted Average Shares Outstanding (Diluted)
26.57M 26.27M 26.01M 23.70M 19.90M
Currency in USD

Fennec Pharmaceuticals Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis